NMN-mediated longevity and the main reasons for decreasing NAD+ level with age

Hypothetical model of NMN-mediated longevity and the main reasons for decreasing NAD+ level with age. NMN may exploit the mechanism for lifespan extension by mitohormesis, which may depend on the AMPK/SIRT1/FOXO pathway. On the other hand, NAD+ degradation accelerates due to DNA damage, chronic oxidative stress, inflammation and consumption of higher NAD+ enzymes such as sirtuins, CD38, CD157, TNKS, poly-adenosine diphosphate ribose polymerase, etc. When NAD+ levels decrease, dysregulation of mitochondrial energy production may occur, leading to aging and decreasing lifespan extension. Supplementation with NMN reverses the aging process, promotes NAD+ levels, and prevents age-related disorders
NMN-mediated longevity and the main reasons for decreasing NAD+ level with age

Publication

Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging (2024) Sajid Ur Rahman, et al. Aging Dis. 2024 Apr 1;15(2). Figure: F3.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates TNKS TNKS ncbigene_symbol TNKS 8658
Homo sapiens Primates PARP PARP ncbigene_synonym PARP1 142
Homo sapiens Primates PARP PARP ncbigene_synonym COL11A2 1302
Homo sapiens Primates PARP PARP famplex_relations PARP2 10038
Homo sapiens Primates PARP PARP famplex_relations PARP3 10039
Homo sapiens Primates PARP PARP famplex_relations PARP4 143
Homo sapiens Primates PARP PARP famplex_relations PARP6 56965
Homo sapiens Primates PARP PARP famplex_relations PARP8 79668
Homo sapiens Primates PARP PARP famplex_relations PARP9 83666
Homo sapiens Primates PARP PARP famplex_relations PARP10 84875
Homo sapiens Primates PARP PARP famplex_relations PARP11 57097
Homo sapiens Primates PARP PARP famplex_relations PARP12 64761
Homo sapiens Primates PARP PARP famplex_relations PARP14 54625
Homo sapiens Primates PARP PARP famplex_relations PARP15 165631
Homo sapiens Primates PARP PARP famplex_relations PARP16 54956
Homo sapiens Primates PARP PARP famplex_relations TNKS2 80351
Homo sapiens Primates PARP PARP famplex_relations TIPARP 25976
Homo sapiens Primates CD38/CD157 CD157 ncbigene_synonym BST1 683
Homo sapiens Primates CD38/CD157 CD38 ncbigene_symbol CD38 952
Homo sapiens Primates AMPK AMPK ncbigene_synonym PRKAA1 5562
Homo sapiens Primates AMPK AMPK ncbigene_synonym PRKAA2 5563
Homo sapiens Primates AMPK AMPK ncbigene_synonym PRKAB1 5564
Homo sapiens Primates AMPK AMPK famplex_relations PRKAB2 5565
Homo sapiens Primates AMPK AMPK famplex_relations PRKAG1 5571
Homo sapiens Primates AMPK AMPK famplex_relations PRKAG2 51422
Homo sapiens Primates AMPK AMPK famplex_relations PRKAG3 53632
Homo sapiens Primates SIRT1/SIR-2.1- SIRT1 ncbigene_symbol SIRT1 23411
Homo sapiens Primates FOXO/DAF-16 FOXO famplex_relations FOXO1 2308
Homo sapiens Primates FOXO/DAF-16 FOXO famplex_relations FOXO3 2309
Homo sapiens Primates FOXO/DAF-16 FOXO famplex_relations FOXO4 4303
Homo sapiens Primates FOXO/DAF-16 FOXO famplex_relations FOXO6 100132074

Chemical mentions

Word Match MeSH Name ChEBI
PARP PARP chebi:62913
cyclic ADP-ribose cyclic ADP-ribose chebi:31445
NMN NMN 3-carbamoyl-1-[5-O-(hydroxyphosphinato)-beta-D-ribofuranosyl]pyridinium chebi:16171
NAD+ NAD+ adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
NAD+ NAD+ adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846

Disease mentions

Word Match MeSH Name DOID